IP Library › Granted Patent US 11,517,360
Granted Patent B2
US 11,517,360 · App. 15/864,796 · Granted Dec 6, 2022

Method and apparatus for treating canine cruciate ligament disease

Inventors: Vivek Shenoy (Redwood City, CA); Mark Deem (Mountain View, CA)
Assignee: The Foundry, LLC
A61B17/8061A61B17/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,517,360
App. No.
15/864,796
Granted
Dec 6, 2022
Kind
B2
Abstract

Prostheses and methods for treating canine cruciate ligament disease are disclosed comprising placement of a specifically configured implant on the femur or tibia to displace targeted muscle or connective tissue associated with the stifle joint so as to reduce cranial tibial thrust.

Claims (25)

1. A device for treating canine cruciate ligament disease in a canine stifle joint, comprising an implant configured and dimensioned to be secured to a canine tibia and to extend under the canine patellar tendon, and to displace the canine patellar tendon sufficiently to produce a therapeutic effect selected from reducing pain, reducing cranial tibial thrust, or increasing stability of the canine stifle joint, wherein said implant comprises:

a fixation portion configured to be secured to one of the lateral side or the medial side of the canine tibia; and

a displacement portion extending centrally from a cranial end of the fixation portion and configured and dimensioned to lie over a more cranial aspect of the tibia relative to the fixation portion positioned under the patellar tendon, and further configured to atraumatically contact and displace the patellar tendon sufficiently to produce at least one said therapeutic effect.

2. The device of claim 1 , wherein the displacement portion includes a bearing surface comprising a smooth surface free of discontinuities to atraumatically engage and displace the target tissue.

3. The device of claim 2 , further comprising a spanning section disposed between the fixation portion and displacement portion.

4. The device of claim 3 , wherein the spanning section and displacement portion are configured and dimensioned to position the bearing surface so as to displace the target tissue greater than about 2 mm up to about 25 mm beyond the natural anatomical track of the target tissue.

5. The device of claim 4 , wherein said displacement is in the range of about 4-15 mm.

6. A device for treating canine cruciate ligament disease in a canine stifle joint by displacing the canine patellar tendon, the device comprising:

a fixation portion configured to be mounted to a canine tibia at a fixation site proximate the upper tibial extremity and medially or laterally of the tibial tuberosity;

a spanning section configured and dimensioned to extend cranially and laterally or medially from the fixation portion in a direction towards the tibial mid-line; and

a displacement portion having an overall curvature around an axis generally parallel to the tibial shaft when the fixation portion is mounted at the fixation site and configured and dimensioned to (i) extend from the spanning section further laterally or medially under patellar tendon and in engagement therewith, and (ii) displace the patellar tendon cranially, anteriorly, medially, anterior-medially or laterally or antero-laterally sufficiently to alter the location, angle or magnitude of forces exerted thereby on the patella so as to achieve a therapeutic effect in patellofemoral compartment of the knee.

7. The device of claim 6 , wherein the therapeutic effect comprises a reduction of loading on an articular surface associated with the canine patella.

8. The device of claim 6 , wherein the displacement portion includes a bearing surface configured to atraumatically engage the canine patellar tendon, the bearing surface being free of holes or other fixation means.

9. The device of claim 6 , wherein said displacement portion and spanning section are configured and dimensioned in combination to displace the canine patellar tendon from a pre-treatment anatomical path by displacement distance of more than about 2 mm and less than about 25 mm when the fixation portion is mounted to the tibia.

10. The device of claim 9 , wherein said displacement is between about 4 mm to about 15 mm.

11. The device of claim 6 , wherein:

the fixation portion is disposed at an angle with the spanning section such that with the prosthesis implanted and the displacement portion engaging the canine patellar tendon, the fixation portion is substantially aligned with the tibial shaft; the spanning section is configured and dimensioned to avoid contact with the medial edge of the canine patellar tendon; and

the displacement portion is further configured and dimensioned to lie substantially parallel to the axis of the tibial plateau when the fixation portion is secured medially of the tibial tuberosity with the fixation portion substantially aligned with the tibial shaft.

12. A device for treating canine cruciate ligament disease in a canine stifle joint by displacing the canine patellar tendon, the device comprising:

a fixation portion configured to be mounted to a canine tibia at a fixation site proximate the upper tibial extremity and medially or laterally of the tibial tuberosity; and

a displacement portion defining a bearing surface and having an overall curvature around an axis generally parallel to the tibial shaft when the fixation portion is mounted at the fixation site, wherein:

the displacement portion is configured and dimensioned to extend laterally or medially under patellar tendon and in engagement therewith;

the bearing surface is free of holes or other fixation means configured to atraumatically engage the canine patellar tendon; and

the device is configured and dimensioned to position the bearing surface, when the fixation portion is mounted at the fixation site on the tibia, to displace the patellar tendon from a pre-treatment anatomical path by displacement distance of more than about 2 mm and less than about 25 mm when the fixation portion is mounted to the tibia so as to reduce loading on an articular surface in the patellofemoral compartment of the knee.

13. The device of claim 12 , further comprising a spanning section configured and dimensioned to extend cranially and laterally or medially from the fixation portion in a direction towards the tibial mid-line to join with the displacement portion to space the displacement portion from the fixation portion thereby.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2018
From: SHENOY, VIVEK; DEEM, MARK
To: COTERA, INC.
Reel/Frame 044564/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2018
From: COTERA, INC.
To: THE FOUNDRY, LLC
Reel/Frame 044564/0576 →
Continuity (7)
Continuation 14642121 · Mar 9, 2015
Continuation PCTUS2013058877 · Sep 10, 2013
Continuation In Part 13002829
Provisional Application 61699089 · Sep 10, 2012
Provisional Application 61237518 · Aug 27, 2009
Provisional Application 61288692 · Dec 21, 2009
Related Publication 20180125550A1 · May 10, 2018